Breaking News Instant updates and real-time market news.

UBER

Uber

$34.70 /

+1.49 (+4.49%)

16:55
08/06/20
08/06
16:55
08/06/20
16:55

Uber sees Q3 adj. EBITDA loss to be in line with Q2

Believes can achieve EBITDA profitability some time in 2021. Comments taken from Q2 earnings conference call.

  • 06

    Aug

  • 07

    Aug

  • 06

    Nov

  • 07

    Nov

  • 11

    Feb

UBER Uber
$34.70 /

+1.49 (+4.49%)

08/05/20 Deutsche Bank
Uber price target lowered to $38 from $40 at Deutsche Bank
07/22/20 Raymond James
Uber resumed with a Market Perform at Raymond James
07/08/20 Wedbush
Postmates stronger fit for Uber, less market share than GrubHub, says Wedbush
07/07/20 KeyBanc
Uber acquisition of Postmates helps drive market rationalization, says KeyBanc

TODAY'S FREE FLY STORIES

On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:19
09/22/20
09/22
16:19
09/22/20
16:19
TSLA

Tesla

$423.90 /

-25.41 (-5.66%)

, CVNA

Carvana

$226.75 /

+52.96 (+30.47%)

, AZO

AutoZone

$1,170.03 /

-7.97 (-0.68%)

, F

Ford

$6.77 /

-0.1 (-1.46%)

, ORCL

Oracle

$60.64 /

-0.22 (-0.36%)

, GME

GameStop

$10.56 /

+1.81 (+20.69%)

, FLGT

Fulgent Genetics

$40.23 /

+2.66 (+7.08%)

, KC

Kingsoft Cloud

$32.31 /

-4.48 (-12.18%)

The major averages were…

ShowHide Related Items >><<
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

CVNA Carvana
$226.75 /

+52.96 (+30.47%)

AZO AutoZone
$1,170.03 /

-7.97 (-0.68%)

F Ford
$6.77 /

-0.1 (-1.46%)

ORCL Oracle
$60.64 /

-0.22 (-0.36%)

GME GameStop
$10.56 /

+1.81 (+20.69%)

FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

KC Kingsoft Cloud
$32.31 /

-4.48 (-12.18%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

07:35 Today Morgan Stanley
Morgan Stanley says 'Battery Day' may be more significant to industry than Tesla
09/17/20 Piper Sandler
Tesla price target raised to $515 from $480 at Piper Sandler
09/17/20 Baird
Tesla could unveil lower cost battery at Battery Day event, says Baird
09/16/20 Credit Suisse
Tesla price target raised to $400 from $280 at Credit Suisse
CVNA Carvana
$226.75 /

+52.96 (+30.47%)

12:28 Today Baird
Carvana price target raised to $240 from $195 at Baird
11:56 Today Stephens
Carvana price target raised to $207 from $165 at Stephens
10:59 Today JPMorgan
JPMorgan ups Carvana to Overweight after 'surprise' profitability acceleration
10:53 Today JPMorgan
Carvana upgraded to Overweight from Neutral at JPMorgan
AZO AutoZone
$1,170.03 /

-7.97 (-0.68%)

13:28 Today Wells Fargo
AutoZone shares should be higher following Q4 report, says Wells Fargo
09/18/20 DA Davidson
AutoZone expected to outperform Q4 consensus estimates, says DA Davidson
09/17/20 Morgan Stanley
AutoZone price target raised to $1,505 from $1,140 at Morgan Stanley
09/14/20 Wells Fargo
AutoZone price target raised to $1,375 from $1,300 at Wells Fargo
F Ford
$6.77 /

-0.1 (-1.46%)

09/18/20 Stifel
Fox Factory upgraded to Buy following pullback at Stifel
09/08/20
Fly Intel: Top five analyst upgrades
09/08/20 Evercore ISI
Evercore ISI giving Ford 'benefit of the doubt,' upgrades to In Line
09/08/20 Evercore ISI
Ford upgraded to In Line from Underperform at Evercore ISI
ORCL Oracle
$60.64 /

-0.22 (-0.36%)

08:22 Today Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
GME GameStop
$10.56 /

+1.81 (+20.69%)

09/14/20
Fly Intel: Top five analyst upgrades
09/14/20 Jefferies
GameStop upgraded to Buy ahead of video game console cycle at Jefferies
09/14/20 Telsey Advisory
GameStop upgraded to Outperform from Market Perform at Telsey Advisory
09/14/20 Jefferies
GameStop upgraded to Buy from Hold at Jefferies
FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

09/03/20 Piper Sandler
Fulgent COVID-19 testing will 'remain robust,' says Piper Sandler
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
08/27/20 Piper Sandler
Piper says medical diagnostics stocks oversold on Abbott COVID-19 test news
08/20/20
Fly Intel: Top five analyst initiationsNewPage
KC Kingsoft Cloud
$32.31 /

-4.48 (-12.18%)

06/29/20 Goldman Sachs
Kingsoft Cloud initiated with a Buy at Goldman Sachs
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

CVNA Carvana
$226.75 /

+52.96 (+30.47%)

AZO AutoZone
$1,170.03 /

-7.97 (-0.68%)

F Ford
$6.77 /

-0.1 (-1.46%)

ORCL Oracle
$60.64 /

-0.22 (-0.36%)

GME GameStop
$10.56 /

+1.81 (+20.69%)

FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

KC Kingsoft Cloud
$32.31 /

-4.48 (-12.18%)

  • 24
    Sep
  • 19
    May
  • 08
    May
  • 14
    Feb
  • 14
    Nov
TSLA Tesla
$423.90 /

-25.41 (-5.66%)

CVNA Carvana
$226.75 /

+52.96 (+30.47%)

F Ford
$6.77 /

-0.1 (-1.46%)

ORCL Oracle
$60.64 /

-0.22 (-0.36%)

GME GameStop
$10.56 /

+1.81 (+20.69%)

FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

CVNA Carvana
$226.75 /

+52.96 (+30.47%)

AZO AutoZone
$1,170.03 /

-7.97 (-0.68%)

F Ford
$6.77 /

-0.1 (-1.46%)

ORCL Oracle
$60.64 /

-0.22 (-0.36%)

GME GameStop
$10.56 /

+1.81 (+20.69%)

FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

KC Kingsoft Cloud
$32.31 /

-4.48 (-12.18%)

TSLA Tesla
$423.90 /

-25.41 (-5.66%)

CVNA Carvana
$226.75 /

+52.96 (+30.47%)

F Ford
$6.77 /

-0.1 (-1.46%)

ORCL Oracle
$60.64 /

-0.22 (-0.36%)

GME GameStop
$10.56 /

+1.81 (+20.69%)

FLGT Fulgent Genetics
$40.23 /

+2.66 (+7.08%)

KC Kingsoft Cloud
$32.31 /

-4.48 (-12.18%)

Hot Stocks
Nike shares jump 8.3% after upbeat Q1 results  16:18
09/22/20
09/22
16:18
09/22/20
16:18
NKE

Nike

$116.98 /

+3.67 (+3.24%)

 
ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:09 Today Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Earnings
Nike reports Q1-end inventories $6.7B, up 15% y/y » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
NKE

Nike

$116.98 /

+3.67 (+3.24%)

"NIKE is recovering…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:09 Today Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Hot Stocks
Kratos Defense collaborates with Microsoft to launch Azure Orbital » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
KTOS

Kratos Defense

$18.88 /

-0.865 (-4.38%)

, MSFT

Microsoft

$207.42 /

+4.75 (+2.34%)

Kratos Defense (KTOS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

10:11 Today
Fly Intel: Top five analyst downgrades
06:07 Today JPMorgan
Kratos Defense downgraded to Neutral on valuation at JPMorgan
04:49 Today JPMorgan
Kratos Defense downgraded to Neutral from Overweight at JPMorgan
08/03/20 Canaccord
Kratos Defense second half catalysts should support shares. says Canaccord
MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

09:25 Today Jefferies
Microsoft deal for Bethesda underscores value of high-quality IP, says Jefferies
07:58 Today Credit Suisse
Microsoft's ZeniMax deal fortifies subscription strategy, says Credit Suisse
06:58 Today Deutsche Bank
Deutsche Bank likes Microsoft acquisition of ZeniMax Media
09/21/20 Jefferies
Microsoft 'doubling down on gaming' with deal, says Jefferies
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

  • 19
    Jun
KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

KTOS Kratos Defense
$18.88 /

-0.865 (-4.38%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

MSFT Microsoft
$207.42 /

+4.75 (+2.34%)

Hot Stocks
Stitch Fix drops 10% to $28.16 after reporting Q4 results  16:17
09/22/20
09/22
16:17
09/22/20
16:17
SFIX

Stitch Fix

$31.30 /

+2.26 (+7.78%)

 
ShowHide Related Items >><<
SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

09/21/20 JPMorgan
Stitch Fix price target raised to $28 from $23 at JPMorgan
09/21/20 Baird
Stitch Fix needs positive forward guidance to propel share higher, says Baird
09/17/20
Fly Intel: Top five analyst initiations
09/17/20
Fly Intel: Top five analyst upgrades
SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

SFIX Stitch Fix
$31.30 /

+2.26 (+7.78%)

Initiation
Baird starts 'pioneer' Neoleukin Therapeutics at Outperform » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
NLTX

Neoleukin Therapeutics

$11.84 /

-0.49 (-3.97%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

16:11 Today Baird
Neoleukin Therapeutics initiated with an Outperform at Baird
08/12/20 Piper Sandler
Neoleukin Therapeutics price target raised to $30 from $28 at Piper Sandler
06/24/20 Piper Sandler
Neoleukin Therapeutics price target raised to $28 from $20 at Piper Sandler
06/23/20 Guggenheim
Neoleukin's preclinical data for NL-201 'checks all the boxes,' says Guggenheim
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

  • 02
    Jul
  • 18
    Dec
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

Technical Analysis
NASDAQ market internals summary » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
KB Home says demand beyond Q3 'remains strong' » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
KBH

KB Home

$40.51 /

+1.61 (+4.14%)

KB Home states: "The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

Earnings
Nike reports Q1 Nike Brand revenue $10B, flat y/y » 16:17
09/22/20
09/22
16:17
09/22/20
16:17
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Revenues for the NIKE…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:09 Today Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Technical Analysis
NYSE market internals summary » 16:16
09/22/20
09/22
16:16
09/22/20
16:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume was average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Earnings
Nike reports Q1 EPS 95c, consensus 47c » 16:16
09/22/20
09/22
16:16
09/22/20
16:16
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

07:09 Today Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Initiation
Plymouth Industrial REIT initiated with an Outperform at Baird » 16:15
09/22/20
09/22
16:15
09/22/20
16:15
PLYM

Plymouth Industrial REIT

$12.48 /

+0.17 (+1.38%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLYM Plymouth Industrial REIT
$12.48 /

+0.17 (+1.38%)

PLYM Plymouth Industrial REIT
$12.48 /

+0.17 (+1.38%)

08/21/20 KeyBanc
Plymouth Industrial REIT valuation attractive, says KeyBanc
12/18/19 KeyBanc
Plymouth Industrial REIT initiated with an Overweight at KeyBanc
PLYM Plymouth Industrial REIT
$12.48 /

+0.17 (+1.38%)

  • 19
    Aug
  • 26
    Sep
Hot Stocks
KB Home reports Q3 deliveries 2,545 vs. 3,022 last year » 16:15
09/22/20
09/22
16:15
09/22/20
16:15
KBH

KB Home

$40.51 /

+1.61 (+4.14%)

Q3 average selling price…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

KBH KB Home
$40.51 /

+1.61 (+4.14%)

Syndicate
Zogenix announces offering of $200M of convertible senior notes » 16:14
09/22/20
09/22
16:14
09/22/20
16:14
ZGNX

Zogenix

$22.59 /

-0.22 (-0.96%)

Zogenix announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

08/24/20 Raymond James
Zogenix initiated with a Market Perform at Raymond James
07/15/20 Stifel
Physician survey suggests Zogenix shares undervalued, says Stifel
06/29/20 Mizuho
Zogenix price target lowered to $55 from $64 at Mizuho
06/26/20 Stifel
FDA approval of Fintepla provides 'sigh of relief' for Zogenix, says Stifel
ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

  • 04
    Mar
ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

ZGNX Zogenix
$22.59 /

-0.22 (-0.96%)

Hot Stocks
KB Home CEO says well positioned to expand scale in 2021 » 16:13
09/22/20
09/22
16:13
09/22/20
16:13
KBH

KB Home

$40.47 /

+1.57 (+4.04%)

CEO Jeffrey Mezger says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.47 /

+1.57 (+4.04%)

KBH KB Home
$40.47 /

+1.57 (+4.04%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.47 /

+1.57 (+4.04%)

KBH KB Home
$40.47 /

+1.57 (+4.04%)

KBH KB Home
$40.47 /

+1.57 (+4.04%)

Syndicate
National Storage launches offering of 4.5M common shares » 16:12
09/22/20
09/22
16:12
09/22/20
16:12
NSA

National Storage

$34.18 /

+0.205 (+0.60%)

National Storage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSA National Storage
$34.18 /

+0.205 (+0.60%)

NSA National Storage
$34.18 /

+0.205 (+0.60%)

07:48 Today Wells Fargo
National Storage price target raised to $37 from $32 at Wells Fargo
08/24/20 Truist
Truist raises price targets on select REITs
04/28/20 Morgan Stanley
Morgan Stanley downgrades Public Storage to Underweight amid record job losses
04/14/20 Baird
National Storage downgraded to Neutral at Baird
NSA National Storage
$34.18 /

+0.205 (+0.60%)

Earnings
KB Home CEO says Q3 profitability 'rose meaningfully' » 16:12
09/22/20
09/22
16:12
09/22/20
16:12
KBH

KB Home

$40.42 /

+1.52 (+3.91%)

CEO Jeffrey Mezger says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.42 /

+1.52 (+3.91%)

KBH KB Home
$40.42 /

+1.52 (+3.91%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.42 /

+1.52 (+3.91%)

KBH KB Home
$40.42 /

+1.52 (+3.91%)

KBH KB Home
$40.42 /

+1.52 (+3.91%)

Hot Stocks
Steelcase restores salaries for most of global workforce » 16:12
09/22/20
09/22
16:12
09/22/20
16:12
SCS

Steelcase

$11.40 /

-0.44 (-3.72%)

"The strength of our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

09/15/20 Sidoti
Steelcase upgraded to Buy from Neutral at Sidoti
08/24/20 Benchmark
Steelcase downgraded to Hold on lack of near-term catalysts at Benchmark
08/24/20 Benchmark
Steelcase downgraded to Hold from Buy at Benchmark
05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

Initiation
Neoleukin Therapeutics initiated with an Outperform at Baird » 16:11
09/22/20
09/22
16:11
09/22/20
16:11
NLTX

Neoleukin Therapeutics

$11.84 /

-0.49 (-3.97%)

Baird initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

08/12/20 Piper Sandler
Neoleukin Therapeutics price target raised to $30 from $28 at Piper Sandler
06/24/20 Piper Sandler
Neoleukin Therapeutics price target raised to $28 from $20 at Piper Sandler
06/23/20 Guggenheim
Neoleukin's preclinical data for NL-201 'checks all the boxes,' says Guggenheim
06/22/20 Piper Sandler
Neoleukin presentations support 'best-in-class approach,' says Piper Sandler
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

  • 02
    Jul
  • 18
    Dec
NLTX Neoleukin Therapeutics
$11.84 /

-0.49 (-3.97%)

Hot Stocks
Stitch Fix reports Q4 active clients of 3.5M, up 9% year-over-year » 16:11
09/22/20
09/22
16:11
09/22/20
16:11
SFIX

Stitch Fix

$31.29 /

+2.25 (+7.75%)

Stitch Fix president…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

09/21/20 JPMorgan
Stitch Fix price target raised to $28 from $23 at JPMorgan
09/21/20 Baird
Stitch Fix needs positive forward guidance to propel share higher, says Baird
09/17/20
Fly Intel: Top five analyst initiations
09/17/20
Fly Intel: Top five analyst upgrades
SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

SFIX Stitch Fix
$31.29 /

+2.25 (+7.75%)

Earnings
KB Home reports Q3 EPS 83c, consensus 53c » 16:10
09/22/20
09/22
16:10
09/22/20
16:10
KBH

KB Home

$40.43 /

+1.53 (+3.93%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$40.43 /

+1.53 (+3.93%)

KBH KB Home
$40.43 /

+1.53 (+3.93%)

09/17/20 Barclays
KB Home price target raised to $42 from $39 at Barclays
09/16/20
Fly Intel: Top five analyst upgrades
09/16/20 Evercore ISI
KB Home upgraded to Outperform from In Line at Evercore ISI
08/13/20 Seaport Global
KB Home downgraded to Neutral on construction cost concerns at Seaport Global
KBH KB Home
$40.43 /

+1.53 (+3.93%)

KBH KB Home
$40.43 /

+1.53 (+3.93%)

KBH KB Home
$40.43 /

+1.53 (+3.93%)

Earnings
Steelcase sees Q3 EPS 12c-18c, consensus 18c » 16:10
09/22/20
09/22
16:10
09/22/20
16:10
SCS

Steelcase

$11.40 /

-0.44 (-3.72%)

"As the number of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

09/15/20 Sidoti
Steelcase upgraded to Buy from Neutral at Sidoti
08/24/20 Benchmark
Steelcase downgraded to Hold on lack of near-term catalysts at Benchmark
08/24/20 Benchmark
Steelcase downgraded to Hold from Buy at Benchmark
05/22/20 Benchmark
Steelcase initiated with a Buy at Benchmark
SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

SCS Steelcase
$11.40 /

-0.44 (-3.72%)

Syndicate
Usio files to sell common stock, no amount given » 16:10
09/22/20
09/22
16:10
09/22/20
16:10
USIO

Usio

$2.31 /

+0.06 (+2.67%)

Ladenburg Thalmann &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USIO Usio
$2.31 /

+0.06 (+2.67%)

USIO Usio
$2.31 /

+0.06 (+2.67%)

08/03/20 Alliance Global Partners
Alliance Global Partners downgrades Usio to Neutral, predicts 'weak' Q2 report
08/03/20 Alliance Global Partners
Usio downgraded to Neutral from Buy at Alliance Global Partners
05/07/20
Fly Intel: Top five analyst initiations
05/07/20 Ladenburg
Ladenburg starts Usio at Buy on digital payments potential
USIO Usio
$2.31 /

+0.06 (+2.67%)

USIO Usio
$2.31 /

+0.06 (+2.67%)

Recommendations
Bluebird Bio review timeline consistent with expectations, says Oppenheimer » 16:09
09/22/20
09/22
16:09
09/22/20
16:09
BLUE

Bluebird Bio

$55.43 /

+1.02 (+1.87%)

, BMY

Bristol-Myers

$58.75 /

+0.98 (+1.70%)

After Bluebird Bio (BLUE)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLUE Bluebird Bio
$55.43 /

+1.02 (+1.87%)

BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

BLUE Bluebird Bio
$55.43 /

+1.02 (+1.87%)

08/06/20 Wedbush
Bluebird Bio price target lowered to $81 from $89 at Wedbush
06/12/20 Piper Sandler
Bluebird Bio update 'modestly positive,' says Piper Sandler
06/10/20 Stifel
Stifel says Bluebird setup 'downside biased,' Crispr's 'upside biased' into EHA
05/13/20 Stifel
Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
BLUE Bluebird Bio
$55.43 /

+1.02 (+1.87%)

BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

  • 19
    May
BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

BLUE Bluebird Bio
$55.43 /

+1.02 (+1.87%)

BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

BMY Bristol-Myers
$58.75 /

+0.98 (+1.70%)

Hot Stocks
Itron announces global cost savings project, aims to save $20M-$25M per year » 16:09
09/22/20
09/22
16:09
09/22/20
16:09
ITRI

Itron

$56.66 /

+0.63 (+1.12%)

Itron announced a plan to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$56.66 /

+0.63 (+1.12%)

ITRI Itron
$56.66 /

+0.63 (+1.12%)

08/25/20 Wolfe Research
Itron initiated with an Underperform at Wolfe Research
08/04/20 Oppenheimer
Itron price target lowered to $75 from $82 at Oppenheimer
06/26/20 Oppenheimer
Itron price target lowered to $82 from $90 at Oppenheimer
05/26/20 Johnson Rice
Itron initiated with a Buy at Johnson Rice
ITRI Itron
$56.66 /

+0.63 (+1.12%)

ITRI Itron
$56.66 /

+0.63 (+1.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.